Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates adding Entinostat to standard chemo-immunotherapy (atezolizumab, carboplatin, etoposide) for previously untreated extensive-stage s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Entinostat (entinostat)
• Etoposide (Etoposide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2023-06-27